Expression of P16(INK4a) in Peripheral Blood T-cells is a Biomarker of Human Aging
Overview
Authors
Affiliations
Expression of the p16(INK4a) tumor suppressor sharply increases with age in most mammalian tissues, and contributes to an age-induced functional decline of certain self-renewing compartments. These observations have suggested that p16(INK4a) expression could be a biomarker of mammalian aging. To translate this notion to human use, we determined p16(INK4a) expression in cellular fractions of human whole blood, and found highest expression in peripheral blood T-lymphocytes (PBTL). We then measured INK4/ARF transcript expression in PBTL from two independent cohorts of healthy humans (170 donors total), and analyzed their relationship with donor characteristics. Expression of p16(INK4a), but not other INK4/ARF transcripts, appeared to exponentially increase with donor chronologic age. Importantly, p16(INK4a) expression did not independently correlate with gender or body-mass index, but was significantly associated with tobacco use and physical inactivity. In addition, p16(INK4a) expression was associated with plasma interleukin-6 concentration, a marker of human frailty. These data suggest that p16(INK4a) expression in PBTL is an easily measured, peripheral blood biomarker of molecular age.
Casso-Chapa B, Vazquez Gonzalez N, Le N, Palaskas N, Nead K, Eutsey L Arterioscler Thromb Vasc Biol. 2025; 45(3):372-385.
PMID: 39817327 PMC: 11864897. DOI: 10.1161/ATVBAHA.124.319870.
Senescence-like Phenotype After Chronic Exposure to Isoproterenol in Primary Quiescent Immune Cells.
Laumann M, Palombo P, Fieres J, Thomas M, Saretzki G, Burkle A Biomolecules. 2025; 14(12.
PMID: 39766235 PMC: 11673961. DOI: 10.3390/biom14121528.
Cellular senescence in acute human infectious disease: a systematic review.
Miller W, Wallace S, Kamm W, Reardon E, Theis-Mahon N, Yousefzadeh M Front Aging. 2024; 5:1500741.
PMID: 39620151 PMC: 11604623. DOI: 10.3389/fragi.2024.1500741.
Emerging insights in senescence: pathways from preclinical models to therapeutic innovations.
Mansfield L, Ramponi V, Gupta K, Stevenson T, Mathew A, Barinda A NPJ Aging. 2024; 10(1):53.
PMID: 39578455 PMC: 11584693. DOI: 10.1038/s41514-024-00181-1.
Wilson S, Mitin N, Miller V, Smitherman A, Carden M Aging (Albany NY). 2024; 16(21):13225-13236.
PMID: 39546497 PMC: 11719104. DOI: 10.18632/aging.206152.